5 Mistakes To Avoid When Scaling Your Biotech Startup

By Frank Stonebanks

Everyone who has worked at a young company has heard some version of the same stat: 90% of startups will ultimately fail.

While I’ve never put much stock in that number, I do know this: Starting a company is difficult. This is particularly true in the biotech space, which is rife with unique challenges — from unreproducible science to the sky-high costs of R&D.